. BG has received fees and honoraria for consultancy for pharmaceutical and industrial companies, participation in expert boards, being a coordinator and investigator for clinical studies (phase 2b, 3, and 4), and a speaker at national and international symposia; and has received grants for clinical projects and research from Bristol-Myers Squibb, SanoÔ¨Å  -Aventis,